Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH (Q69914660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

4

A V Schally

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1

A Zalatnai

1 reference

6 October 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

author name string

J I Paz-Bouza

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

T W Redding

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

85-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

Proliferation of Dunning R-3327 rat prostatic adenocarcinoma and of its sublines (CUA and CUB).

6 October 2019

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Purification and partial characterization of prostate-derived growth factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

The presence of LHRH-like receptors in Dunning R3327H prostate tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Histological findings in the rat prostate cancer model during treatment with a luteinizing hormone-releasing hormone agonist and novantrone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Stability of sublines in the R3327-H rat prostatic tumor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990120111

Identifiers

DOI

10.1002/PROS.2990120111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2894651%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference